Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients.
Company profile
Ticker
UTMD
Exchange
Website
CEO
Kevin Cornwell
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Utah Medical Products Ltd. • Columbia Medical & Surgical, Inc. • Femcare Group Limited • Femcare Limited • Femcare Australia Pty Ltd • Femcare N.Z. Ltd • Utah Medical Products Canada Inc. ...
IRS number
870342734
UTMD stock data
Latest filings (excl ownership)
8-K
UTMD Reports Audited Year 2022 and Fourth Quarter Financial Performance
31 Jan 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
Other Events
1 Nov 22
8-K
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
25 Oct 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
8-K
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022
27 Jul 22
SD
Conflict minerals disclosure
31 May 22
10-Q
2022 Q1
Quarterly report
11 May 22
8-K
Submission of Matters to a Vote of Security Holders
9 May 22
8-K
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2022
26 Apr 22
Latest ownership filings
4
PAUL O RICHINS
17 Mar 23
SC 13G
T. Rowe Price Investment Management, Inc.
14 Feb 23
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
13 Feb 23
4
BARBARA A PAYNE
9 Feb 23
SC 13G/A
FMR LLC
9 Feb 23
SC 13G/A
VANGUARD GROUP INC
9 Feb 23
SC 13G/A
BlackRock Inc.
1 Feb 23
4
Brian Koopman
6 Dec 22
4
PAUL O RICHINS
21 Nov 22
4
PAUL O RICHINS
17 Nov 22
Financial summary
| Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Institutional ownership, Q4 2022
3.2% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 81 |
| Opened positions | 12 |
| Closed positions | 3 |
| Increased positions | 30 |
| Reduced positions | 22 |
| 13F shares | Current |
|---|---|
| Total value | 191.59 bn |
| Total shares | 2.55 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 382.03 k | $38.41 bn |
| T. Rowe Price Investment Management | 341.92 k | $34.19 bn |
| Renaissance Technologies | 210.61 k | $21.17 mm |
| BLK Blackrock | 205.51 k | $20.66 bn |
| Vanguard | 167.69 k | $16.86 bn |
| Dimensional Fund Advisors | 153.37 k | $15.42 mm |
| Rice Hall James & Associates | 114.37 k | $11.50 bn |
| HealthInvest Partners AB | 94.00 k | $9.45 bn |
| JPM JPMorgan Chase & Co. | 83.21 k | $8.37 mm |
| Ranger Investment Management | 75.09 k | $7.55 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 17 Mar 23 | Richins Paul O | Common Stock | Gift | Dispose G | Yes | No | 92.5 | 150 | 13.88 k | 22,161 |
| 8 Feb 23 | Payne Barbara A | Common Stock | Gift | Dispose G | No | No | 89.9974 | 500 | 45.00 k | 4,838 |
| 6 Dec 22 | Brian Koopman | Common Stock | Option exercise | Acquire M | No | No | 74.64 | 500 | 37.32 k | 992 |
| 6 Dec 22 | Brian Koopman | Common Stock | Payment of exercise | Dispose F | No | No | 101.88 | 366 | 37.29 k | 492 |
| 6 Dec 22 | Brian Koopman | Employee Stock Option - Right to Buy Common Stock | Option exercise | Dispose M | No | No | 74.64 | 500 | 37.32 k | 4,100 |
| 18 Nov 22 | Richins Paul O | Common Stock | Sell | Dispose S | Yes | No | 90.81 | 449 | 40.77 k | 22,311 |
| 17 Nov 22 | Richins Paul O | Common Stock | Sell | Dispose S | Yes | No | 90 | 161 | 14.49 k | 22,760 |